Research articlePublished 22 Jul 2016
Clinical experience with a low-dose fixed combination of perindopril plus indapamide in a primary-care setting: the PRETEND study
Abstract
PRETEND was a multicenter observational survey carried out in primary-care clinics across Spain. It was designed to determine general practitioners’ perceptions regarding their clinical experience with the fixed low-dose combination of perindopril 2 mg plus indapamide 0.625 mg in everyday practice. A total of 3198 patients, mean age 62.4 ± 10.9 years, were included. Before combined therapy, blood pressure was 161.8 ± 13.0/94.6 ± 9.2 mmHg and after treatment it was 139.8 ± 12.1/82.9 ± 8.4 mmHg (p < 0.001). The blood pressure control rate increased from 1.1 to 38.7%. Most physicians considered the efficacy and tolerability of perindopril plus indapamide to be good or very good, and most patients were satisfied or very satisfied with the therapy.
Keywords
Subjects
General & Internal MedicineFollow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Practice
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Vivencio Barrios”
- BylineArticles whose byline prints “Carlos Escobar”
- BylineArticles whose byline prints “Juan Antonio Divison”
- BylineArticles whose byline prints “Francisco Medialdea”